Several blood-based biomarkers, such as alpha-fetoprotein (AFP), alpha-l-fucosidase (AFU), and des-gamma-carboxy prothrombin (DCP), have been used for the early detection of HCC over the past decades; however, these biomarkers are neither sensitive nor specific.75 This evidence concerns the gene AFP and hepatocellular carcinoma.